Pratt Collard Advisory Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$259K Hold
1,127
0.17% 90
2021
Q1
$211K Buy
+1,127
New +$220K 0.15% 96
2020
Q2
Sell
-8,812
Closed -$1.22M 94
2020
Q1
$1.22M Buy
8,812
+27
+0.3% +$3.71K 1.23% 26
2019
Q4
$1.16M Sell
8,785
-50
-0.6% -$5.8K 0.88% 36
2019
Q3
$988K Hold
8,835
0.78% 39
2019
Q2
$979K Sell
8,835
-110
-1% -$13K 0.77% 37
2019
Q1
$1.16M Sell
8,945
-805
-8% -$97.9K 0.93% 33
2018
Q4
$1.13M Buy
9,750
+550
+6% +$61.4K 1.03% 31
2018
Q3
$987K Buy
9,200
+3,525
+62% +$352K 0.79% 43
2018
Q2
$484K Buy
+5,675
New +$466K 0.42% 67

Other funds holding LLY

Pratt Collard Advisory Partners's LLY Position: Q2 2021 in Review

Pratt Collard Advisory Partners held its Eli Lilly (LLY) position steady in Q2 2021 at 1,127 shares worth $259K. The position accounts for 0.17% of the portfolio, ranked #90.

Pratt Collard Advisory Partners first reported a position in LLY in Q2 2018 and has held it in 10 quarters since. The position peaked at $1.22M in Q1 2020. 2,022 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Pratt Collard Advisory Partners held 1,127 shares of Eli Lilly worth $259K as of Q2 2021.
  • Pratt Collard Advisory Partners left its Eli Lilly share count unchanged in Q2 2021.
  • Eli Lilly made up 0.17% of Pratt Collard Advisory Partners's portfolio in Q2 2021, its #90 holding.
  • Pratt Collard Advisory Partners first reported a position in Eli Lilly in Q2 2018 and has held it in 10 quarters since.
  • Pratt Collard Advisory Partners's Eli Lilly position peaked at $1.22M in Q1 2020.
  • 2,022 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.